Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nast
S Grabbe

Showing results (161-170 of 223) with videos related to

Pageof 23
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|October 16, 2015
The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrumentR N Werner, B Marinović, S Rosumeck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulationS Beissert, J A Bluestone, I Mindt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesisS Beissert, D Rühlemann, T Mohammad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacityC Curiel-Lewandrowski, K Mahnke, M Labeur, et al.
The Journal of Investigative Dermatology|August 1, 1994
In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactionsA Schwarz, S Grabbe, H Riemann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2017
Methods report: European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPCC Dressler, S Rosumeck, R N Werner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2012
Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatmentT C Lucka, D Pathirana, A Sammain, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 11, 2005
Reporting and classification of patient safety events in a cardiothoracic intensive care unit and cardiothoracic postoperative care unitPatricia A Nast, Michael Avidan, Carolyn B Harris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Impaired cutaneous immune responses in Thy-1-deficient miceS Beissert, H T He, A O Hueber, et al.
The British Journal of Dermatology|November 25, 2017
Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumabR B Warren, A Brnabic, D Saure, et al.
Pageof 23

Showing results (161-170 of 223) with videos related to

Sort By:
Pageof 23
Journal of the European Academy of Dermatology and Venereology : JEADV|October 16, 2015
The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrumentR N Werner, B Marinović, S Rosumeck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulationS Beissert, J A Bluestone, I Mindt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesisS Beissert, D Rühlemann, T Mohammad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacityC Curiel-Lewandrowski, K Mahnke, M Labeur, et al.
The Journal of Investigative Dermatology|August 1, 1994
In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactionsA Schwarz, S Grabbe, H Riemann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2017
Methods report: European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPCC Dressler, S Rosumeck, R N Werner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2012
Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatmentT C Lucka, D Pathirana, A Sammain, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 11, 2005
Reporting and classification of patient safety events in a cardiothoracic intensive care unit and cardiothoracic postoperative care unitPatricia A Nast, Michael Avidan, Carolyn B Harris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Impaired cutaneous immune responses in Thy-1-deficient miceS Beissert, H T He, A O Hueber, et al.
The British Journal of Dermatology|November 25, 2017
Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumabR B Warren, A Brnabic, D Saure, et al.
Pageof 23